{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:32:37Z","timestamp":1793892757432,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"GRAIL Inc, US"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,11,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Smokers are eligible for lung cancer screening using low dose CT (LDCT) if they have a sufficiently high risk of lung cancer. In England, for example, people are eligible if their estimated risk using either of two validated models (PLCO\n                      <jats:sub>m2012<\/jats:sub>\n                      and Liverpool Lung Project) exceeds a certain threshold. Risk is often estimated using only cigarette consumption (duration and number per day), yet many smokers also use other cancer-causing tobacco products.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SUMMIT is a prospective cohort study of a\u00a0LDCT screening\u00a0service. We evaluated the impact of cigars, pipes, and cigarillos on lung cancer risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 13,000 participants who were current\/former cigarette smokers, 511 (1 in 25) were also regular users of cigars, pipes, or cigarillos. The 5-year cumulative lung cancer incidence in people who currently smoked both types of tobacco products was 8.85%, versus 5.74% for cigarette only current smokers. Among these 511 participants, the percentage whose risk was below the screening eligibility threshold ignoring other tobacco products which then exceeded the threshold including these products was 0.6% using LLPv2, and 8.2% using PLCO\n                      <jats:sub>m2012<\/jats:sub>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>All tobacco consumption should be considered when determining screening eligibility to avoid missing those who can benefit from LDCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>Clinicaltrials.gov no: NCT03934866.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03578-9","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:04:05Z","timestamp":1786115045000},"page":"1641-1648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of cigar, cigarillo and pipe smoking on lung cancer risk and screening eligibility"],"prefix":"10.1038","volume":"135","author":[{"given":"Simran","family":"Vaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Mullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amyn","family":"Bhamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Creamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuen R.","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Prendecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyam","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Tisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Arthur-Darwka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-7516","authenticated-orcid":false,"given":"Neal","family":"Navani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Devaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SUMMIT consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-5939","authenticated-orcid":false,"given":"Sam M.","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5570-5070","authenticated-orcid":false,"given":"Allan","family":"Hackshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"3578_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3578_CR2","doi-asserted-by":"crossref","unstructured":"US Preventive Services Task Force. Screening for Lung Cancer. US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325:962\u201370.","DOI":"10.1001\/jama.2021.1117"},{"key":"3578_CR3","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/S1470-2045(23)00104-3","volume":"24","author":"EL O\u2019Dowd","year":"2023","unstructured":"O\u2019Dowd EL, Lee RW, Akram AR, Bartlett EC, Bradley SH, Brain K, et al. Defining the road map to UK national lung cancer screening programme. Lancet Oncol. 2023;24:e207\u201318.","journal-title":"Lancet Oncol"},{"key":"3578_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/cncr.34758","volume":"130","author":"R Landy","year":"2023","unstructured":"Landy R, Cheung LC, Young CD, Chaturvedi AK, Katki HA. Absolute lung cancer risk increases among individuals with >15 quit-years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines. Cancer. 2023;130:201\u201315.","journal-title":"Cancer"},{"key":"3578_CR5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/M21-0398","volume":"174","author":"K Kerlikowske","year":"2021","unstructured":"Kerlikowske K, Bibbins-Domingo K. Toward Risk-Based Breast Cancer Screening. Ann Intern Med. 2021;174:710\u20131.","journal-title":"Ann Intern Med"},{"key":"3578_CR6","doi-asserted-by":"publisher","first-page":"l5558","DOI":"10.1136\/bmj.l5558","volume":"367","author":"P Autier","year":"2019","unstructured":"Autier P. Personalised and risk based cancer screening. BMJ. 2019;367:l5558.","journal-title":"BMJ"},{"key":"3578_CR7","doi-asserted-by":"crossref","unstructured":"Tammem\u00e4gi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368:728\u201336.","DOI":"10.1056\/NEJMoa1211776"},{"key":"3578_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/sj.bjc.6604158","volume":"98","author":"A Cassidy","year":"2008","unstructured":"Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer. 2008;98:270\u20136.","journal-title":"Br J Cancer"},{"key":"3578_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/thoraxjnl-2020-215158","volume":"76","author":"JK Field","year":"2021","unstructured":"Field JK, Vulkan D, Davies MPA, Duffy SW, Gabe R. Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation. Thorax. 2021;76:161\u20138.","journal-title":"Thorax"},{"key":"3578_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1200\/JCO.2016.69.2467","volume":"35","author":"DC Muller","year":"2017","unstructured":"Muller DC, Johansson M, Brennan P. Lung cancer risk prediction model incorporating lung function: development and validation in the UK biobank prospective cohort study. J Clin Oncol. 2017;35:861\u20139.","journal-title":"J Clin Oncol"},{"key":"3578_CR11","doi-asserted-by":"crossref","unstructured":"Liao W, Coupland CAC, Burchardt J, Baldwin DR, DART initiative, Gleeson FV, et al. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19.67 million people and evaluation of model performance against seven other risk prediction models. Lancet Respir Med. 2023;11:685\u201397.","DOI":"10.1016\/S2213-2600(23)00050-4"},{"key":"3578_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-385","volume":"12","author":"PN Lee","year":"2012","unstructured":"Lee PN, Forey BA, Coombs KJ. Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer. 2012;12:385.","journal-title":"BMC Cancer"},{"key":"3578_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1617-5","volume":"15","author":"CM Chang","year":"2015","unstructured":"Chang CM, Corey CG, Rostron BL, Apelberg BJ. Systematic review of cigar smoking and all cause and smoking related mortality. BMC Public Health. 2015;15:390.","journal-title":"BMC Public Health"},{"key":"3578_CR14","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/thoraxjnl-2021-218634","volume":"77","author":"JL Dickson","year":"2022","unstructured":"Dickson JL, Hall H, Horst C, Tisi S, Verghese P, Mullin AM, et al. Telephone risk-based eligibility assessment for low-dose CT lung cancer screening. Thorax. 2022;77:1036\u201340.","journal-title":"Thorax"},{"key":"3578_CR15","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2468-2667(22)00258-4","volume":"8","author":"JL Dickson","year":"2023","unstructured":"Dickson JL, Hall H, Horst C, Tisi S, Verghese P, Mullin AM, et al. SUMMIT consortium. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study. Lancet Public Health. 2023;8:e130\u2013e140.","journal-title":"Lancet Public Health"},{"key":"3578_CR16","doi-asserted-by":"publisher","first-page":"e1001764","DOI":"10.1371\/journal.pmed.1001764","volume":"11","author":"MC Tammem\u00e4gi","year":"2014","unstructured":"Tammem\u00e4gi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med. 2014;11:e1001764.","journal-title":"PLoS Med"},{"key":"3578_CR17","unstructured":"Reilly V, Millar H. Clinical Guideline: Smoking Cessation Guidelines for Community Pharmacy. [online] Available at: https:\/\/www.communitypharmacy.scot.nhs.uk\/media\/3771\/smoking-cessation-guidelines-v4.pdf (2020)."},{"key":"3578_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(25)00082-8","volume":"26","author":"A Bhamani","year":"2025","unstructured":"Bhamani A, Creamer A, Verghese P, Prendecki R, Horst C, Tisi S, et al. Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study. Lancet Oncol. 2025;26:609\u201319.","journal-title":"Lancet Oncol"},{"key":"3578_CR19","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/sj.bjc.6602078","volume":"91","author":"A Crispo","year":"2004","unstructured":"Crispo A, Brennan P, J\u00f6ckel K-H, Schaffrath-Rosario A, Wichmann HE, Nyberg F, et al. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer. 2004;91:1280\u20136.","journal-title":"Br J Cancer"},{"key":"3578_CR20","unstructured":"Alavanja M, Baron JA, Brownson RC, Buffler PA, DeMarini DM, Djordjevic MV, et al. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 83, Tobacco smoke and involuntary smoking. WHO\/IARC, Lyon, France 2004."},{"key":"3578_CR21","first-page":"21","volume":"9","author":"OG Joly","year":"1984","unstructured":"Joly OG, Lubin JH, Caraballoso M. Dark tobacco and lung cancer in Cuba. PubMed. 1984;9:21\u201326.","journal-title":"PubMed"},{"key":"3578_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/jnci\/73.2.377","volume":"73","author":"JH Lubin","year":"1984","unstructured":"Lubin JH, Richter BS, Blot WJ. Lung cancer risk with cigar and pipe use. JNCI: J Natl Cancer Inst. 1984;73:377\u201381.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"3578_CR23","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM199906103402301","volume":"340","author":"C Iribarren","year":"1999","unstructured":"Iribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med. 1999;340:1773\u201380.","journal-title":"N Engl J Med"},{"key":"3578_CR24","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/ije\/dyg206","volume":"32","author":"A Shaper","year":"2003","unstructured":"Shaper A, Wannamethee S, Walker M. Pipe and cigar smoking and major cardiovascular events, cancer incidence and all-cause mortality in middle-aged British men. Int J Epidemiol. 2003;32:802\u20138.","journal-title":"Int J Epidemiol"},{"key":"3578_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF00124258","volume":"3","author":"WH Chow","year":"1992","unstructured":"Chow WH, Schuman LM, McLaughlin JK, Bjelke E, Gridley G, Wacholder S, et al. A cohort study of tobacco use, diet, occupation, and lung cancer mortality. Cancer Causes Control. 1992;3:247\u201354.","journal-title":"Cancer Causes Control"},{"key":"3578_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/jnci\/djh144","volume":"96","author":"SJ Henley","year":"2004","unstructured":"Henley SJ, Thun MJ, Chao A, Calle EE. Association between exclusive pipe smoking and mortality from cancer and other diseases. JNCI J Natl Cancer Inst. 2004;96:853\u201361.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"3578_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/jnci\/92.4.333","volume":"92","author":"JA Shapiro","year":"2000","unstructured":"Shapiro JA. Cigar smoking in men and risk of death from tobacco-related cancers. J Natl Cancer Inst. 2000;92:333\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"3578_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jamainternmed.2017.8625","volume":"178","author":"CH Christensen","year":"2018","unstructured":"Christensen CH, Rostron B, Cosgrove C, Altekruse SF, Hartman AM, Gibson JT, et al. Association of cigarette, cigar, and pipe use with mortality risk in the US population. JAMA Intern Med. 2018;178:469.","journal-title":"JAMA Intern Med"},{"key":"3578_CR29","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ijc.2910370605","volume":"37","author":"S Benhamou","year":"1986","unstructured":"Benhamou S, Benhamou E, Flamant R. Lung cancer risk associated with cigar and pipe smoking. Int J Cancer. 1986;37:825\u20139.","journal-title":"Int J Cancer"},{"key":"3578_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0091-7435(88)90077-1","volume":"17","author":"IT Higgins","year":"1988","unstructured":"Higgins IT, Mahan CM, Wynder EL. Lung cancer among cigar and pipe smokers. Preventive Med. 1988;17:116\u201328.","journal-title":"Preventive Med"},{"key":"3578_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/jnci\/91.8.697","volume":"91","author":"P Boffetta","year":"1999","unstructured":"Boffetta P, Pershagen G, Jockel KH, Forastiere F, Gaborieau V, Heinrich J, et al. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. JNCI J Natl Cancer Inst. 1999;91:697\u2013701.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"3578_CR32","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/ijc.25252","volume":"127","author":"VA McCormack","year":"2010","unstructured":"McCormack VA, Agudo A, Dahm CC, Overvad K, Olsen A, Tjonneland A, et al. Cigar and pipe smoking and cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2010;127:2402\u201311.","journal-title":"Int J Cancer"},{"key":"3578_CR33","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/1097-0142(196708)20:8<1288::AID-CNCR2820200812>3.0.CO;2-L","volume":"20","author":"T Abelin","year":"1967","unstructured":"Abelin T, Gsell OR. Relative risk of pulmonary cancer in cigar and pipe smokers. Cancer. 1967;20:1288\u201396.","journal-title":"Cancer"},{"key":"3578_CR34","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/1940-6207.CAPR-17-0084","volume":"10","author":"J Malhotra","year":"2017","unstructured":"Malhotra J, Borron C, Freedman ND, Abnet CC, van den Brandt PA, White E, et al. Association between cigar or pipe smoking and cancer risk in men: a pooled analysis of five cohort studies. Cancer Prev Res. 2017;10:704\u20139.","journal-title":"Cancer Prev Res"},{"key":"3578_CR35","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1136\/bmj.314.7098.1860","volume":"314","author":"NJ Wald","year":"1997","unstructured":"Wald NJ, Watt HC. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. BMJ. 1997;314:1860\u201360.","journal-title":"BMJ"},{"key":"3578_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12016-013-8372-0","volume":"46","author":"M Schivo","year":"2013","unstructured":"Schivo M, Avdalovic MV, Murin S. Non-cigarette tobacco and the lung. Clin Rev Allergy Immunol. 2013;46:34\u201353.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3578_CR37","doi-asserted-by":"crossref","unstructured":"Jackson SE, Shahab L, Brown J. Trends in exclusive non-cigarette tobacco smoking in England: a population survey. Nicotine Tob Res., 2024;27:2013\u2013223.","DOI":"10.1093\/ntr\/ntae021"},{"key":"3578_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41568-021-00423-4","volume":"22","author":"SS Hecht","year":"2022","unstructured":"Hecht SS, Hatsukami DK. Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention. Nat Rev Cancer. 2022;22:143\u201355.","journal-title":"Nat Rev Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03578-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03578-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03578-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:53:05Z","timestamp":1793890385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03578-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,11,20]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03578-9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"University College London and University College London Hospital (in which several authors are employed) received funding for the SUMMIT study from GRAIL. AH has received support for travel for an advisory board for Roche; and is on academic scientific advisory boards for Adela Bio, Roche, and Luventix, who are developing multicancer blood or urine tests, but receives no payments or honoraria from any of these companies. SMJ has received grant income from GRAIL; is an unpaid member of a GRAIL advisory board. NN reports honoraria for non-promotional educational talks or advisory boards from Amgen, AstraZeneca, AXANA, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, EQRx, Fujifilm, Guardant Health, Intuitive, Janssen, Lilly, Merck Sharp & Dohme, Olympus, and Roche; has received support for attending meetings or travel from Astra Zeneca, Fujifilm, Intuitive, Merck Sharp & Dohme and Olympus; and is a member of the British Thoracic Oncology Group steering committee, director of the UK Lung Cancer Coalition, and clinical director of the National Lung Cancer Audit. AN has received a consultation fee from Merck Sharp & Dohme; received honoraria for speaking engagements from Mevis Medical Solutions; and is an honorary executive committee member of the British Society of Thoracic Imaging, co-chair of the British Thoracic Society Pulmonary Nodule Guideline Development Group, is a Lung Taskforce member for the British Lung Foundation, and clinical lead for the NHS England Targeted Lung Health Checks Programme. AD reports consulting fees from AstraZeneca, Boehringer Ingelheim, and Brainomix; and stock or stock options from Brainomix. MM reports support for travel to an international conference from GRAIL. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all participants. The study was conducted in accordance with relevant guidelines and regulations. The study had national ethics approval from the Health Research Authority (REC reference number 17\/LO\/2004).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Authors provided their consent to submit and publish the final version of this manuscript.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}